[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE20080129A1 - Procedimiento de conjugacion - Google Patents

Procedimiento de conjugacion

Info

Publication number
PE20080129A1
PE20080129A1 PE2007000349A PE2007000349A PE20080129A1 PE 20080129 A1 PE20080129 A1 PE 20080129A1 PE 2007000349 A PE2007000349 A PE 2007000349A PE 2007000349 A PE2007000349 A PE 2007000349A PE 20080129 A1 PE20080129 A1 PE 20080129A1
Authority
PE
Peru
Prior art keywords
pnag
carrier protein
group
activated
activation
Prior art date
Application number
PE2007000349A
Other languages
English (en)
Spanish (es)
Inventor
Ralph Leon Biemans
Pierre Duvivier
Thomas Maira-Litran
Original Assignee
Glaxosmithkline Biolog Sa
Brighman And Women S Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43217117&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080129(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0606416A external-priority patent/GB0606416D0/en
Priority claimed from GB0606417A external-priority patent/GB0606417D0/en
Application filed by Glaxosmithkline Biolog Sa, Brighman And Women S Hospital Inc filed Critical Glaxosmithkline Biolog Sa
Publication of PE20080129A1 publication Critical patent/PE20080129A1/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PE2007000349A 2006-03-30 2007-03-28 Procedimiento de conjugacion PE20080129A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78758706P 2006-03-30 2006-03-30
US78724906P 2006-03-30 2006-03-30
GB0606416A GB0606416D0 (en) 2006-03-30 2006-03-30 Immunogenic composition
GB0606417A GB0606417D0 (en) 2006-03-30 2006-03-30 Immunogenic composition

Publications (1)

Publication Number Publication Date
PE20080129A1 true PE20080129A1 (es) 2008-04-08

Family

ID=43217117

Family Applications (3)

Application Number Title Priority Date Filing Date
PE2007000349A PE20080129A1 (es) 2006-03-30 2007-03-28 Procedimiento de conjugacion
PE2007000353A PE20080774A1 (es) 2006-03-30 2007-03-28 Composicion inmunogenica que comprende pnag de estafilococos conjugada con una proteina portadora y polisacarido u oligosacarido capsular de s. aureus
PE2011001600A PE20120262A1 (es) 2006-03-30 2007-03-28 Procedimiento para la preparacion de inmunoconjugados que comprenden polisacarido u oligosacarido capsular de s. aureus junto con la proteina portadora

Family Applications After (2)

Application Number Title Priority Date Filing Date
PE2007000353A PE20080774A1 (es) 2006-03-30 2007-03-28 Composicion inmunogenica que comprende pnag de estafilococos conjugada con una proteina portadora y polisacarido u oligosacarido capsular de s. aureus
PE2011001600A PE20120262A1 (es) 2006-03-30 2007-03-28 Procedimiento para la preparacion de inmunoconjugados que comprenden polisacarido u oligosacarido capsular de s. aureus junto con la proteina portadora

Country Status (4)

Country Link
CL (1) CL2007000839A1 (zh)
JO (2) JO3418B1 (zh)
PE (3) PE20080129A1 (zh)
TW (1) TWI494124B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102120761B (zh) * 2010-12-24 2013-02-06 新疆维吾尔自治区畜牧科学院兽医研究所 一种无荚膜型金黄色葡萄球菌胞外多糖-蛋白质偶联物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102739T2 (tr) * 1999-03-19 2001-12-21 Smithkline Beecham Biologicals S.A. Aşı
EP1601381A2 (en) * 2003-03-07 2005-12-07 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
JP4764820B2 (ja) * 2003-06-23 2011-09-07 バクスター・インターナショナル・インコーポレイテッド ワクチン用担体タンパク質

Also Published As

Publication number Publication date
PE20080774A1 (es) 2008-08-08
JO3418B1 (ar) 2019-10-20
PE20120262A1 (es) 2012-03-30
TWI494124B (zh) 2015-08-01
CL2007000839A1 (es) 2008-01-25
TW200806314A (en) 2008-02-01
JO3420B1 (ar) 2019-10-20

Similar Documents

Publication Publication Date Title
AR060188A1 (es) Procedimiento de conjugacion
EA200970471A1 (ru) Микроорганизмы или их фракции, обеспечивающие активацию клеточного иммунитета против углеводов
BRPI0514982A (pt) adjuvante de glicosilceramida para antìgenos de sacarìdeo
DOP2009000269A (es) Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
EA200800952A1 (ru) Конъюгаты антитело-лекарство и способы применения
AR069980A1 (es) Inmunoconjugados dirigidos contra cd 138 y sus usos
EA201001322A1 (ru) Вакцины против хламидиоза
PE20080035A1 (es) Anticuerpos monoclonales humanos para la quinasa-1 tipo receptor de activina
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
CR20110206A (es) Método de uso de una sepa de bacillus subtilis para mejorar la salud de animales
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
CY1113190T1 (el) Μεθοδος αγωγης της αιμολυτικης νοσου
CR9558A (es) Formulaciones de quinina
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
AR075604A1 (es) Anticuerpos contra un ligando que induce proliferacion (april)
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
BRPI0906478B8 (pt) anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende
BRPI0611820B8 (pt) método de identificar uma infecção por e. canis ou e. chaffeensis
TW200740458A (en) Vaccination against dengue virus infection
UA85559C2 (en) Aminobenzophenone compounds
EA200700965A1 (ru) Трегалоза и/или изомальтулоза в качестве носителя для сухой ароматической композиции
EA200701995A1 (ru) Способы уменьшения кальцификации

Legal Events

Date Code Title Description
FG Grant, registration